Avenue Therapeutics【ATXI】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.92

買値

1.85

売値

1.92

出来高

43,590

1.80 日の範囲 1.98

1.60 52 週間の範囲 26.4675

時価総額

3.67M

前日終値

1.94

始値

1.94

時刻

1.9

最終取引時間

財務取引量

US$ 82,302

VWAP

1.8881

平均取引量 (3 か月)

48,301

発行済株式数

1,911,633

配当利回り

PER

-0.36

1 株当たり利益 (EPS)

-5.43

歳入

純利益

-10.38M

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.avenuetx.com

本社

Dover, Delaware, USA

設立

Avenue Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ATXI. The last closing price for Avenue Therapeutics was US$1.94. Over the last year, Avenue Therapeutics shares have traded in a share price range of US$ 1.60 to US$ 26.4675.

Avenue Therapeutics currently has 1,911,633 shares in issue. The market capitalisation of Avenue Therapeutics is US$3.71 million. Avenue Therapeutics has a price to earnings ratio (PE ratio) of -0.36.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.12	6.66666666667	1.8	1.99	1.64	31571	1.83790611	CS
4	0.08	4.34782608696	1.84	2	1.63	30547	1.83929875	CS
12	-0.18	-8.57142857143	2.1	2.7	1.6	48301	2.064879	CS
26	-1.65	-46.218487395	3.57	3.9313	1.6	46181	2.50136532	CS
52	-10.5825	-84.6430713857	12.5025	26.4675	1.6	1504057	18.3247609	CS
156	-995.955	-99.8075911312	997.875	1406.25	1.6	1764048	315.62746873	CS
260	-10404.33	-99.9815495495	10406.25	14130	1.6	1148493	702.26406672	CS

ATXI - Frequently Asked Questions (FAQ)

What is the current Avenue Therapeutics share price?

The current share price of Avenue Therapeutics is US$ 1.92

How many Avenue Therapeutics shares are in issue?

Avenue Therapeutics has 1,911,633 shares in issue

What is the market cap of Avenue Therapeutics?

The market capitalisation of Avenue Therapeutics is USD 3.71M

What is the 1 year trading range for Avenue Therapeutics share price?

Avenue Therapeutics has traded in the range of US$ 1.60 to US$ 26.4675 during the past year

What is the PE ratio of Avenue Therapeutics?

The price to earnings ratio of Avenue Therapeutics is -0.36

What is the reporting currency for Avenue Therapeutics?

Avenue Therapeutics reports financial results in USD

What is the latest annual profit for Avenue Therapeutics?

The latest annual profit of Avenue Therapeutics is USD -10.38M

What is the registered address of Avenue Therapeutics?

The registered address for Avenue Therapeutics is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901

What is the Avenue Therapeutics website address?

The website address for Avenue Therapeutics is www.avenuetx.com

Which industry sector does Avenue Therapeutics operate in?

Avenue Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
WATTEnergous Corporation	US$ 2.70 (556.61%)	226.21M
NXUNXU Inc	US$ 1.52 (524.49%)	572.73M
HOLOMicroCloud Hologram Inc	US$ 6.40 (166.67%)	221.85M
INTZIntrusion Inc	US$ 5.67 (162.50%)	132.97M
SMXSMX Security Matters Public Company	US$ 0.803558 (127.25%)	370.63M
ICGIntchains Group Ltd	US$ 3.39 (-63.67%)	1.77M
ABPAbpro Holdings Inc	US$ 2.10 (-53.23%)	2.17M
LITMSnow Lake Resources Ltd	US$ 0.9212 (-42.43%)	69.28M
TRAWTraws Pharma Inc	US$ 8.33 (-37.93%)	1.2M
BDMDBaird Medical Investment Holdings Ltd	US$ 1.07 (-37.79%)	153.54k
NXUNXU Inc	US$ 1.52 (524.49%)	572.73M
SMXSMX Security Matters Public Company	US$ 0.803558 (127.25%)	370.63M
VINCVincerx Inc	US$ 0.3243 (67.16%)	335.59M
XTIAXTI Aerospace Inc	US$ 0.0395 (0.00%)	292.67M
WATTEnergous Corporation	US$ 2.70 (556.61%)	226.21M